Susquehanna International Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-22,800
Closed -$618K 10274
2015
Q4
$618K Sell
22,800
-28,900
-56% -$744K ﹤0.01% 6363
2015
Q3
$1.13M Buy
51,700
+20,200
+64% +$516K ﹤0.01% 5471
2015
Q2
$898K Buy
+31,500
New +$918K ﹤0.01% 6446
2015
Q1
Sell
-34,400
Closed -$908K 10420
2014
Q4
$908K Buy
34,400
+16,300
+90% +$477K ﹤0.01% 6057
2014
Q3
$546K Buy
+18,100
New +$561K ﹤0.01% 7034
2014
Q2
Sell
-14,400
Closed -$466K 10373
2014
Q1
$466K Sell
14,400
-77,900
-84% -$2.73M ﹤0.01% 6852
2013
Q4
$3.36M Buy
92,300
+60,400
+189% +$2.35M ﹤0.01% 3499
2013
Q3
$1.24M Sell
31,900
-9,700
-23% -$391K ﹤0.01% 4921
2013
Q2
$1.56M Buy
+41,600
New +$1.64M ﹤0.01% 4303

Other funds holding MR

Susquehanna International Group's MR Position: Q1 2016 in Review

Susquehanna International Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 104,111 shares — an estimated $2.82M sold.

Susquehanna International Group first reported a position in MR in Q4 2013 and held it in 8 quarters. The position peaked at $7.14M in Q1 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Susquehanna International Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Susquehanna International Group sold 104,111 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $2.82M.
  • Susquehanna International Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 8 quarters.
  • Susquehanna International Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $7.14M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.